{
"NDC": {
"NDCCode": "70069-810-01",
"PackageDescription": "100 mL in 1 BOTTLE (70069-810-01) ",
"NDC11Code": "70069-0810-01",
"ProductNDC": "70069-810",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Valganciclovir Hydrochloride",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Valganciclovir",
"DosageFormName": "FOR SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20220115",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA213306",
"LabelerName": "Somerset Therapeutics, LLC",
"SubstanceName": "VALGANCICLOVIR",
"StrengthNumber": "50",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog [EXT]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-01-27",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20220115",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}